Inventor · disambiguated record
Sophie M. Lehar
Also filed as: LEHAR SOPHIE · LEHAR SOPHIE M
10 granted patents·17 pending applications·1,395 citations·filing 1996–2025
89Inventor score
Top patents by PatentIndex Score
27 records- 0196US9920123B2Anti-PD-L1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2016·Granted Mar 20, 2018·30 cites·30 claims
- 0295US8217149B2Anti-PD-L1 antibodies, compositions and articles of manufactureIRVING BRYAN·Filed 2009·Granted Jul 10, 2012·1.3k cites·61 claims
- 0386US9803002B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Oct 31, 2017·6 cites·58 claims
- 0485US2023287127A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2023·Application pending·0 cites
- 0578US2025382370A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2025·Application pending·0 cites
- 0673US6190909B1TH2-specific geneMILLENNIUM PHARM INC·Filed 1997·Granted Feb 20, 2001·39 cites·17 claims
- 0773US2021032345A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2020·Application pending·0 cites
- 0871US9884126B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Granted Feb 6, 2018·1 cites·26 claims
- 0967US2015322153A1Anti-pd-l1 antibodies and articles of manufactureGENENTECH INC·Filed 2014·Application pending·0 cites
- 1067US2019016807A1Anti-pd-l1 antibodies, compositions and articles of manufactureGENENTECH INC·Filed 2018·Application pending·0 cites
- 1165US7078175B2Antibodies for apoptosis EI24 protein and methods of useIMMUNOGEN INC·Filed 2003·Granted Jul 18, 2006·0 cites·17 claims
- 1265US2014065135A1Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunityGENENTECH INC·Filed 2013·Application pending·0 cites
- 1362US2013045202A1Anti-pd-l1 antibodies and articles of manufactureGENENTECH INC·Filed 2012·Application pending·0 cites
- 1462US2013045201A1Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunityGENENTECH INC·Filed 2012·Application pending·0 cites
- 1562US2013045200A1Methods of using anti-pd-l1 antibodies and their use to treat infection resulting from t-cell dysfunctionGENENTECH INC·Filed 2012·Application pending·0 cites
- 1660US2009081642A1Novel apoptosis gene EI24, compositions, and methods of useAPOPTOSIS TECHNOLOGY INC·Filed 2006·Application pending·0 cites
- 1760US2016222117A1Nucleic acid encoding anti-pd-l1 antibodiesGENENTECH INC·Filed 2015·Application pending·0 cites
- 1857US10570192B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2017·Granted Feb 25, 2020·0 cites·11 claims
- 1954US5843659AApoptosis gene EI24, compositions, and methods of useAPOPTOSIS TECHNOLOGY INC·Filed 1996·Granted Dec 1, 1998·5 cites·18 claims
- 2053US2018085470A1Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2017·Application pending·0 cites
- 2152US2014356375A1Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2014·Application pending·0 cites
- 2251US9895450B2Anti-wall teichoic antibodies and conjugatesGENENTECH INC·Filed 2015·Granted Feb 20, 2018·0 cites·23 claims
- 2347US2005202013A1Novel Th2-specific molecules and uses thereofMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 2445US2018021450A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2544US2002164697A1Novel Th2-specific molecules and uses thereofMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 2640US2018125995A1Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2734US6586204B2Apoptosis gene EI24, compositions, and methods of useAPOPTOSIS TECHNOLOGY INC·Filed 1998·Granted Jul 1, 2003·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →